The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling
The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus...
Saved in:
Published in | Journal of virology Vol. 91; no. 3 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures. |
---|---|
AbstractList | The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures. |
Author | Best, Sonja M. |
Author_xml | – sequence: 1 givenname: Sonja M. surname: Best fullname: Best, Sonja M. organization: Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27881649$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1rGzEQxUVJaJyPW89Fxx66iUbSaqVLIYS6dcgXxAntSWhlraOylhxJNvi_77pJSht6KAwMzPzm8Zi3j3ZCDA6hd0COAag8Ob-fHBNQDalAvEEjIEpWdQ18B40IobSqmfy2h_Zz_kEIcC74W7RHGylBcDVC36cPDl-asMFjY13GscNlmIx7s_Zrn1YZX93W-CbF4nzAQ52GYuYx-LzYstPN0uEJnoTiUudSDPjWz4PpfZgfot3O9NkdPfcDdDf-PD37Wl1cf5mcnV5UlktWKibbhrW8FnbGOuiY6agVZuiKtpbPpOka4BaIq5kAKcmMCtUKa4hqHDTcsAP06Ul3uWoXbmZdKMn0epn8wqSNjsbrvzfBP-h5XOuacs64GgQ-PAuk-LhyueiFz9b1vQkurrIGKSRjNVXyP1DOlFCM0AF9_6et335eXj8A9AmwKeacXKetL6b4uHXpew1Eb_PVQ776V74axHD08dXRi-4_8Z-QjKW8 |
CitedBy_id | crossref_primary_10_3389_fimmu_2021_671471 crossref_primary_10_1186_s12974_021_02180_5 crossref_primary_10_3390_microorganisms10050854 crossref_primary_10_1016_j_bbrc_2019_06_064 crossref_primary_10_1007_s00705_023_05883_7 crossref_primary_10_3390_vaccines12080865 crossref_primary_10_1128_JVI_01086_20 crossref_primary_10_1016_j_actatropica_2021_106199 crossref_primary_10_1016_j_bbamcr_2023_119536 crossref_primary_10_1016_j_antiviral_2018_09_006 crossref_primary_10_1038_s42003_024_05768_8 crossref_primary_10_1155_2020_1372494 crossref_primary_10_1128_JVI_00640_19 crossref_primary_10_3390_pathogens8040169 crossref_primary_10_1016_j_virusres_2024_199431 crossref_primary_10_1016_j_mam_2021_100994 crossref_primary_10_1073_pnas_2220005120 crossref_primary_10_3390_pathogens9070589 crossref_primary_10_1016_j_immuni_2020_11_019 crossref_primary_10_1128_JVI_00313_19 crossref_primary_10_1007_s00335_018_9775_2 crossref_primary_10_1016_j_celrep_2021_109888 crossref_primary_10_1021_acs_jproteome_9b00318 crossref_primary_10_3389_fcimb_2018_00149 crossref_primary_10_1073_pnas_2403235121 crossref_primary_10_3390_ijms21165906 crossref_primary_10_3389_fimmu_2022_829433 crossref_primary_10_1016_j_ajog_2018_08_035 crossref_primary_10_3390_v14051026 crossref_primary_10_1073_pnas_2101713118 crossref_primary_10_1007_s00018_018_2968_8 crossref_primary_10_1002_rmv_2166 crossref_primary_10_1155_2017_1734151 crossref_primary_10_3390_v10070340 crossref_primary_10_1021_acs_jnatprod_1c01161 crossref_primary_10_1016_j_jve_2024_100368 crossref_primary_10_3390_v17010001 crossref_primary_10_1080_07391102_2020_1742205 crossref_primary_10_3390_cells8121519 crossref_primary_10_1186_s12862_017_1107_8 crossref_primary_10_1016_j_jsb_2025_108196 crossref_primary_10_3390_v13102099 crossref_primary_10_1128_mBio_02904_18 crossref_primary_10_3390_cells13070598 crossref_primary_10_21769_BioProtoc_2643 crossref_primary_10_1038_s41564_019_0421_x crossref_primary_10_1016_j_cyto_2020_155342 crossref_primary_10_1016_j_jviromet_2024_115053 crossref_primary_10_3390_v10070350 crossref_primary_10_1099_jgv_0_000992 crossref_primary_10_1016_j_bbrc_2017_10_016 crossref_primary_10_1002_eji_201847483 crossref_primary_10_1089_jir_2019_0097 crossref_primary_10_15252_embr_202357424 crossref_primary_10_3390_immuno4040033 crossref_primary_10_3390_v10120712 crossref_primary_10_1042_BCJ20220037 crossref_primary_10_1128_JVI_00058_20 crossref_primary_10_1093_nar_gkaa242 crossref_primary_10_3389_fviro_2022_935933 crossref_primary_10_1016_j_ebiom_2018_12_010 crossref_primary_10_3390_v14081666 crossref_primary_10_3389_fimmu_2023_1172000 crossref_primary_10_3390_v12101059 crossref_primary_10_3389_fimmu_2022_1031868 crossref_primary_10_3389_fcimb_2022_946957 crossref_primary_10_3389_fmicb_2023_1257024 crossref_primary_10_1016_j_jprot_2022_104619 crossref_primary_10_1038_s41564_024_01726_6 crossref_primary_10_1128_JVI_00163_17 crossref_primary_10_3389_fmicb_2022_757084 crossref_primary_10_3390_cells9040899 crossref_primary_10_3390_cells9061476 crossref_primary_10_1016_j_virol_2025_110456 crossref_primary_10_1242_dmm_040816 crossref_primary_10_3390_ijms25179424 crossref_primary_10_3390_vaccines9030294 crossref_primary_10_2217_fvl_2019_0037 crossref_primary_10_1096_fj_201900518R crossref_primary_10_1128_JVI_00383_21 crossref_primary_10_7554_eLife_31919 crossref_primary_10_1111_cmi_12737 crossref_primary_10_3389_fimmu_2018_00722 crossref_primary_10_4049_jimmunol_1701773 crossref_primary_10_2174_0929867326666190111115132 crossref_primary_10_1007_s00018_018_2751_x crossref_primary_10_1016_j_tracli_2017_05_005 crossref_primary_10_3390_v15051094 crossref_primary_10_1089_vim_2019_0082 crossref_primary_10_3390_ijms23010489 crossref_primary_10_3390_v9040091 crossref_primary_10_1016_j_ejmech_2021_113698 crossref_primary_10_3390_v16020202 crossref_primary_10_1128_JVI_01301_21 crossref_primary_10_1080_22221751_2022_2049983 crossref_primary_10_1080_07391102_2022_2141882 crossref_primary_10_1128_jvi_01982_22 crossref_primary_10_3390_v12070765 crossref_primary_10_3390_v14081808 crossref_primary_10_1007_s13365_017_0595_z crossref_primary_10_3389_fcimb_2021_574067 crossref_primary_10_1080_21645515_2019_1609823 crossref_primary_10_1007_s12010_021_03526_8 crossref_primary_10_1016_j_jsps_2020_10_005 crossref_primary_10_1016_j_cyto_2019_02_009 crossref_primary_10_3390_microorganisms8091406 crossref_primary_10_1016_j_ymthe_2020_11_011 crossref_primary_10_1021_acsinfecdis_8b00373 crossref_primary_10_1016_j_virs_2022_12_005 crossref_primary_10_1128_JVI_00178_20 crossref_primary_10_1099_jgv_0_001400 crossref_primary_10_3390_ph18030283 crossref_primary_10_1038_s41598_020_64199_7 crossref_primary_10_3390_ijms21113812 crossref_primary_10_1016_j_celrep_2019_05_040 crossref_primary_10_1126_scisignal_aaw8549 crossref_primary_10_3390_microorganisms12091840 crossref_primary_10_1128_JVI_01778_18 crossref_primary_10_1007_s12250_018_0067_5 crossref_primary_10_3390_v9060143 |
Cites_doi | 10.1074/jbc.M200018200 10.1016/j.chom.2016.05.009 10.1371/journal.ppat.1003265 10.1128/IAI.71.6.3000-3009.2003 10.1371/journal.pntd.0004658 10.1016/j.tcb.2014.05.001 10.1128/JVI.02188-08 10.1016/j.chom.2011.08.004 10.1128/JVI.03083-12 10.1128/JVI.00421-14 10.1038/nri2623 10.1126/science.aab3369 10.1089/vim.2010.0126 10.1146/annurev-virology-100114-055007 10.3389/fcimb.2014.00116 10.1038/nrm909 10.1128/JVI.79.9.5414-5420.2005 10.1016/j.jmb.2013.11.023 10.1038/nrmicro.2016.125 10.1038/nrmicro2950 10.1016/j.chom.2007.09.003 10.1016/j.chom.2016.03.010 10.1128/JVI.74.11.4957-4966.2000 10.1016/j.it.2015.02.002 10.1038/sj.onc.1203482 10.1016/j.chom.2014.07.015 10.1016/j.vaccine.2009.03.007 10.1016/j.immuni.2012.11.013 10.1128/JVI.80.6.2913-2923.2006 10.1128/JVI.00176-10 10.1016/j.jmb.2016.07.017 10.1146/annurev-immunol-032713-120231 10.1128/JVI.73.11.9247-9255.1999 10.1128/JVI.02097-12 10.1016/S0065-3527(03)61008-0 10.1128/mBio.01316-15 10.1128/JVI.79.20.12828-12839.2005 10.1016/j.chom.2010.10.007 10.1093/emboj/18.4.959 10.1128/JVI.00271-09 10.1371/journal.ppat.1004682 10.1016/j.virol.2015.01.019 10.4161/jkst.27715 10.1371/journal.ppat.1005143 10.1038/nri3133 10.1007/978-3-642-37765-5_2 10.1128/JVI.00791-07 10.1038/nri3210 10.1371/journal.pntd.0004682 10.1007/s00726-008-0055-4 10.1016/j.cell.2016.08.004 10.1128/JVI.02830-06 10.1128/JVI.02505-14 10.1002/pmic.201300001 10.1128/JVI.02050-10 10.1038/nri3581 10.3389/fmicb.2013.00176 10.1016/j.chom.2008.10.007 10.15252/embr.201642627 10.1016/j.ymeth.2011.08.003 10.1016/j.chom.2013.07.005 10.1038/nri3865 10.1111/j.1462-5822.2007.01076.x 10.1016/j.chom.2015.06.007 10.1126/science.aaf8325 10.1128/JVI.00207-12 10.1016/j.mib.2010.05.009 10.1128/JVI.00252-16 10.1371/journal.ppat.1005451 10.1074/jbc.M309749200 10.1128/JVI.00768-06 10.1371/journal.ppat.1000721 10.4049/jimmunol.174.12.8163 10.1128/JVI.78.17.9285-9294.2004 10.1038/nrmicro2595 10.1089/jir.2012.0117 10.1038/nature09907 10.3390/v4030397 10.1371/journal.pone.0090704 10.1038/nrmicro2675 10.1128/JVI.02283-06 10.1128/JVI.01239-15 10.1016/j.it.2015.01.004 10.1016/j.cytogfr.2014.08.004 10.1099/vir.0.014506-0 10.1128/JVI.02714-05 10.1371/journal.ppat.1002934 10.1086/605847 10.1016/j.chom.2016.06.001 10.1038/nature09489 10.4161/viru.2.3.16162 10.1038/nature12060 10.1128/JVI.01161-09 10.1128/JVI.80.9.4623-4632.2006 10.1073/pnas.1514978112 10.1128/JVI.01305-07 10.4269/ajtmh.16-0111 10.1128/JVI.01488-13 10.1128/JVI.79.3.1343-1350.2005 10.1038/nri3806 10.1089/jir.2009.0069 10.1128/JVI.79.3.1934-1942.2005 10.1073/pnas.2335168100 10.1016/j.vaccine.2012.11.015 10.1016/j.stem.2016.08.005 10.1016/j.cell.2016.05.008 10.1371/journal.ppat.1003549 |
ContentType | Journal Article |
Copyright | Copyright © 2017 American Society for Microbiology. Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2017 American Society for Microbiology. – notice: Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 7U9 H94 5PM |
DOI | 10.1128/JVI.01970-16 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | MEDLINE - Academic CrossRef AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Minireview |
EISSN | 1098-5514 |
ExternalDocumentID | PMC5244349 27881649 10_1128_JVI_01970_16 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) grantid: 1ZIAAI001125-02 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM CGR CUY CVF ECM EIF NPM RHF UCJ 7X8 7T5 7U9 H94 5PM |
ID | FETCH-LOGICAL-c483t-38b73b456cd3f1f3af2c6af3a92bc4d8af714c10e5361880d269b6ca097e174a3 |
ISSN | 0022-538X |
IngestDate | Thu Aug 21 18:41:48 EDT 2025 Fri Jul 11 08:13:01 EDT 2025 Fri Jul 11 02:44:46 EDT 2025 Thu Jan 02 23:00:25 EST 2025 Tue Jul 01 01:02:47 EDT 2025 Thu Apr 24 22:59:17 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | NS5 interferons yellow fever virus antagonism JAK-STAT West Nile virus dengue virus Zika virus flavivirus tick-borne encephalitis virus |
Language | English |
License | Copyright © 2017 American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c483t-38b73b456cd3f1f3af2c6af3a92bc4d8af714c10e5361880d269b6ca097e174a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Article-1 ObjectType-Feature-2 Citation Best SM. 2017. The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling. J Virol 91:e01970-16. https://doi.org/10.1128/JVI.01970-16. |
OpenAccessLink | https://jvi.asm.org/content/jvi/91/3/e01970-16.full.pdf |
PMID | 27881649 |
PQID | 1843969302 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244349 proquest_miscellaneous_1868335298 proquest_miscellaneous_1843969302 pubmed_primary_27881649 crossref_citationtrail_10_1128_JVI_01970_16 crossref_primary_10_1128_JVI_01970_16 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-02-01 |
PublicationDateYYYYMMDD | 2017-02-01 |
PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2017 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_28_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_85_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_89_2 e_1_3_2_100_2 e_1_3_2_104_2 e_1_3_2_81_2 e_1_3_2_108_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_31_2 e_1_3_2_73_2 e_1_3_2_12_2 e_1_3_2_58_2 e_1_3_2_96_2 e_1_3_2_3_2 e_1_3_2_77_2 e_1_3_2_92_2 e_1_3_2_50_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_86_2 e_1_3_2_21_2 e_1_3_2_63_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_67_2 e_1_3_2_82_2 e_1_3_2_103_2 e_1_3_2_107_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_78_2 e_1_3_2_97_2 e_1_3_2_2_2 e_1_3_2_93_2 e_1_3_2_70_2 e_1_3_2_111_2 e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_87_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_60_2 e_1_3_2_83_2 e_1_3_2_102_2 e_1_3_2_106_2 e_1_3_2_9_2 e_1_3_2_37_2 e_1_3_2_18_2 Lindenbach BD (e_1_3_2_23_2) 2007 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_33_2 e_1_3_2_79_2 e_1_3_2_14_2 e_1_3_2_56_2 e_1_3_2_98_2 e_1_3_2_94_2 e_1_3_2_71_2 e_1_3_2_110_2 e_1_3_2_90_2 Mashimo T (e_1_3_2_35_2) 2008; 321 e_1_3_2_27_2 e_1_3_2_65_2 e_1_3_2_42_2 e_1_3_2_84_2 e_1_3_2_69_2 e_1_3_2_46_2 e_1_3_2_88_2 e_1_3_2_61_2 e_1_3_2_80_2 e_1_3_2_101_2 e_1_3_2_109_2 e_1_3_2_105_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_76_2 e_1_3_2_99_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_95_2 e_1_3_2_4_2 e_1_3_2_91_2 e_1_3_2_72_2 Gubler DJ (e_1_3_2_22_2) 2007 |
References_xml | – ident: e_1_3_2_100_2 doi: 10.1074/jbc.M200018200 – ident: e_1_3_2_64_2 doi: 10.1016/j.chom.2016.05.009 – ident: e_1_3_2_58_2 doi: 10.1371/journal.ppat.1003265 – ident: e_1_3_2_95_2 doi: 10.1128/IAI.71.6.3000-3009.2003 – ident: e_1_3_2_5_2 doi: 10.1371/journal.pntd.0004658 – ident: e_1_3_2_57_2 doi: 10.1016/j.tcb.2014.05.001 – ident: e_1_3_2_54_2 doi: 10.1128/JVI.02188-08 – ident: e_1_3_2_36_2 doi: 10.1016/j.chom.2011.08.004 – ident: e_1_3_2_60_2 doi: 10.1128/JVI.03083-12 – ident: e_1_3_2_104_2 doi: 10.1128/JVI.00421-14 – ident: e_1_3_2_19_2 doi: 10.1038/nri2623 – ident: e_1_3_2_42_2 doi: 10.1126/science.aab3369 – ident: e_1_3_2_83_2 doi: 10.1089/vim.2010.0126 – ident: e_1_3_2_24_2 doi: 10.1146/annurev-virology-100114-055007 – ident: e_1_3_2_93_2 doi: 10.3389/fcimb.2014.00116 – ident: e_1_3_2_34_2 doi: 10.1038/nrm909 – ident: e_1_3_2_50_2 doi: 10.1128/JVI.79.9.5414-5420.2005 – ident: e_1_3_2_44_2 doi: 10.1016/j.jmb.2013.11.023 – ident: e_1_3_2_62_2 doi: 10.1038/nrmicro.2016.125 – ident: e_1_3_2_32_2 doi: 10.1038/nrmicro2950 – ident: e_1_3_2_98_2 doi: 10.1016/j.chom.2007.09.003 – ident: e_1_3_2_2_2 doi: 10.1016/j.chom.2016.03.010 – ident: e_1_3_2_48_2 doi: 10.1128/JVI.74.11.4957-4966.2000 – ident: e_1_3_2_103_2 doi: 10.1016/j.it.2015.02.002 – ident: e_1_3_2_89_2 doi: 10.1038/sj.onc.1203482 – ident: e_1_3_2_68_2 doi: 10.1016/j.chom.2014.07.015 – ident: e_1_3_2_81_2 doi: 10.1016/j.vaccine.2009.03.007 – ident: e_1_3_2_69_2 doi: 10.1016/j.immuni.2012.11.013 – ident: e_1_3_2_29_2 doi: 10.1128/JVI.80.6.2913-2923.2006 – ident: e_1_3_2_37_2 doi: 10.1128/JVI.00176-10 – ident: e_1_3_2_14_2 doi: 10.1016/j.jmb.2016.07.017 – ident: e_1_3_2_9_2 doi: 10.1146/annurev-immunol-032713-120231 – ident: e_1_3_2_56_2 doi: 10.1128/JVI.73.11.9247-9255.1999 – ident: e_1_3_2_78_2 doi: 10.1128/JVI.02097-12 – ident: e_1_3_2_72_2 doi: 10.1016/S0065-3527(03)61008-0 – ident: e_1_3_2_61_2 doi: 10.1128/mBio.01316-15 – ident: e_1_3_2_47_2 doi: 10.1128/JVI.79.20.12828-12839.2005 – ident: e_1_3_2_59_2 doi: 10.1016/j.chom.2010.10.007 – ident: e_1_3_2_88_2 doi: 10.1093/emboj/18.4.959 – ident: e_1_3_2_106_2 doi: 10.1128/JVI.00271-09 – ident: e_1_3_2_110_2 doi: 10.1371/journal.ppat.1004682 – ident: e_1_3_2_27_2 doi: 10.1016/j.virol.2015.01.019 – ident: e_1_3_2_21_2 doi: 10.4161/jkst.27715 – ident: e_1_3_2_91_2 doi: 10.1371/journal.ppat.1005143 – ident: e_1_3_2_12_2 doi: 10.1038/nri3133 – ident: e_1_3_2_70_2 doi: 10.1007/978-3-642-37765-5_2 – ident: e_1_3_2_97_2 doi: 10.1128/JVI.00791-07 – ident: e_1_3_2_8_2 doi: 10.1038/nri3210 – ident: e_1_3_2_4_2 doi: 10.1371/journal.pntd.0004682 – ident: e_1_3_2_79_2 doi: 10.1007/s00726-008-0055-4 – ident: e_1_3_2_7_2 doi: 10.1016/j.cell.2016.08.004 – ident: e_1_3_2_73_2 doi: 10.1128/JVI.02830-06 – ident: e_1_3_2_71_2 doi: 10.1128/JVI.02505-14 – ident: e_1_3_2_87_2 doi: 10.1002/pmic.201300001 – ident: e_1_3_2_77_2 doi: 10.1128/JVI.02050-10 – ident: e_1_3_2_33_2 doi: 10.1038/nri3581 – ident: e_1_3_2_20_2 doi: 10.3389/fmicb.2013.00176 – ident: e_1_3_2_40_2 doi: 10.1016/j.chom.2008.10.007 – ident: e_1_3_2_65_2 doi: 10.15252/embr.201642627 – ident: e_1_3_2_107_2 doi: 10.1016/j.ymeth.2011.08.003 – ident: e_1_3_2_102_2 doi: 10.1016/j.chom.2013.07.005 – ident: e_1_3_2_13_2 doi: 10.1038/nri3865 – ident: e_1_3_2_85_2 doi: 10.1111/j.1462-5822.2007.01076.x – ident: e_1_3_2_28_2 doi: 10.1016/j.chom.2015.06.007 – ident: e_1_3_2_17_2 doi: 10.1126/science.aaf8325 – ident: e_1_3_2_41_2 doi: 10.1128/JVI.00207-12 – ident: e_1_3_2_16_2 doi: 10.1016/j.mib.2010.05.009 – ident: e_1_3_2_63_2 doi: 10.1128/JVI.00252-16 – ident: e_1_3_2_105_2 doi: 10.1371/journal.ppat.1005451 – ident: e_1_3_2_90_2 doi: 10.1074/jbc.M309749200 – ident: e_1_3_2_80_2 doi: 10.1128/JVI.00768-06 – ident: e_1_3_2_75_2 doi: 10.1371/journal.ppat.1000721 – ident: e_1_3_2_49_2 doi: 10.4049/jimmunol.174.12.8163 – ident: e_1_3_2_82_2 doi: 10.1128/JVI.78.17.9285-9294.2004 – ident: e_1_3_2_52_2 doi: 10.1038/nrmicro2595 – ident: e_1_3_2_76_2 doi: 10.1089/jir.2012.0117 – ident: e_1_3_2_10_2 doi: 10.1038/nature09907 – start-page: 1101 volume-title: Fields virology year: 2007 ident: e_1_3_2_23_2 – ident: e_1_3_2_45_2 doi: 10.3390/v4030397 – ident: e_1_3_2_101_2 doi: 10.1371/journal.pone.0090704 – ident: e_1_3_2_39_2 doi: 10.1038/nrmicro2675 – ident: e_1_3_2_74_2 doi: 10.1128/JVI.02283-06 – ident: e_1_3_2_109_2 doi: 10.1128/JVI.01239-15 – ident: e_1_3_2_15_2 doi: 10.1016/j.it.2015.01.004 – ident: e_1_3_2_18_2 doi: 10.1016/j.cytogfr.2014.08.004 – ident: e_1_3_2_67_2 doi: 10.1099/vir.0.014506-0 – ident: e_1_3_2_86_2 doi: 10.1128/JVI.02714-05 – ident: e_1_3_2_111_2 doi: 10.1371/journal.ppat.1002934 – ident: e_1_3_2_55_2 doi: 10.1086/605847 – ident: e_1_3_2_94_2 doi: 10.1016/j.chom.2016.06.001 – ident: e_1_3_2_26_2 doi: 10.1038/nature09489 – ident: e_1_3_2_38_2 doi: 10.4161/viru.2.3.16162 – ident: e_1_3_2_53_2 doi: 10.1038/nature12060 – ident: e_1_3_2_84_2 doi: 10.1128/JVI.01161-09 – ident: e_1_3_2_99_2 doi: 10.1128/JVI.80.9.4623-4632.2006 – ident: e_1_3_2_25_2 doi: 10.1073/pnas.1514978112 – ident: e_1_3_2_31_2 doi: 10.1128/JVI.01305-07 – volume: 321 start-page: 85 year: 2008 ident: e_1_3_2_35_2 article-title: Innate resistance to flavivirus infections and the functions of 2′-5′ oligoadenylate synthetases publication-title: Curr Top Microbiol Immunol – ident: e_1_3_2_3_2 doi: 10.4269/ajtmh.16-0111 – ident: e_1_3_2_30_2 doi: 10.1128/JVI.01488-13 – ident: e_1_3_2_51_2 doi: 10.1128/JVI.79.3.1343-1350.2005 – ident: e_1_3_2_11_2 doi: 10.1038/nri3806 – ident: e_1_3_2_43_2 doi: 10.1089/jir.2009.0069 – ident: e_1_3_2_92_2 doi: 10.1128/JVI.79.3.1934-1942.2005 – ident: e_1_3_2_96_2 doi: 10.1073/pnas.2335168100 – start-page: 1153 volume-title: Fields virology year: 2007 ident: e_1_3_2_22_2 – ident: e_1_3_2_46_2 doi: 10.1016/j.vaccine.2012.11.015 – ident: e_1_3_2_66_2 doi: 10.1016/j.stem.2016.08.005 – ident: e_1_3_2_6_2 doi: 10.1016/j.cell.2016.05.008 – ident: e_1_3_2_108_2 doi: 10.1371/journal.ppat.1003549 |
SSID | ssj0014464 |
Score | 2.5730448 |
SecondaryResourceType | review_article |
Snippet | The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes,... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Animals Arthropod Vectors - virology Arthropoda Flaviviridae Flavivirus Flavivirus - classification Flavivirus - physiology Flavivirus Infections - metabolism Flavivirus Infections - transmission Flavivirus Infections - virology Host-Pathogen Interactions Humans Interferon Type I - antagonists & inhibitors Interferon Type I - metabolism Janus Kinases - metabolism Minireview Protein Binding Signal Transduction STAT Transcription Factors - metabolism Structure-Activity Relationship Viral Nonstructural Proteins - chemistry Viral Nonstructural Proteins - metabolism Viral Proteins - metabolism West Nile virus Zika virus |
Title | The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27881649 https://www.proquest.com/docview/1843969302 https://www.proquest.com/docview/1868335298 https://pubmed.ncbi.nlm.nih.gov/PMC5244349 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3db9MwEMAtGELiBfFN-ZKR4KlKSezEiR8BUa1D5WUbKk-RP0fRlE5dOwn-eu6cNEm3ggZSlUbppWnza893Pt8dIW9Y4a21RkecKxWlLFaRtnEMe0w6bzOeG4zoTr-I_eP0YJbNuj56IbtkpUfm1868kv-hCseAK2bJ_gPZ9k3hAOwDX9gCYdhem_EUA_bjsLCqCfePT9XF_GK-XIMKO8wwFQA7WoaJjQpjUBX2xQBZdEGHk3pO0LslKo75CdrlzWB21WTFnLj-LPwHV2eMHC6qH2o4HfWnEGBYitvlGN2SftB8s3pQqDUhFhpFc6qvKmXS-0nw3RqYYVbBwdfJCIzHPI6SHYWuLw1A7bLA4JCwooSzy3B2mYib5BYDDyB4y5PPbYAIvNh0UwgeP_kmp4EV7_rX3rY2rrgQl1fC9kyLo3vkbnOD6fsa8H1yw1UPyO26S-jPh-QbYKaImQbMdOEpYKYdZgqYaYOZwqPDjLKImU5oh5m2mB-R4_Gno4_7UdMRIzJpwVcRL3TONdi8xnKfeK48M0LBs2TapLZQPk9Sk8Qu4wIL7VkmpBZGxTJ34Hoq_pjsVYvKPSXUSyNim2fWW5-yPNaJsMxo0NDOq5iZARlu7lxpmnLx2LXktNxFaUDettJndZmUP8i93kAoQY9hcEpVbrE-L7HvkMS-nOxvMiLkCMpiQJ7U4NqrMeyLIFI5IPkW0lYA66hvv1LNv4d66hmYuDyVz675HZ6TO92f6AXZWy3X7iVYpiv9KvxGfwNaWYz9 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Many+Faces+of+the+Flavivirus+NS5+Protein+in+Antagonism+of+Type+I+Interferon+Signaling&rft.jtitle=Journal+of+virology&rft.au=Best%2C+Sonja+M.&rft.date=2017-02-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=91&rft.issue=3&rft_id=info:doi/10.1128%2FJVI.01970-16&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_01970_16 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |